
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?

13 жовт. 2026 р.
Обсяг $3.09K

Дата завершення: 13 жовт. 2026 р.
Результати

$16.6B
Обсяг $211.88
45%
45%

$16.8B
Обсяг $181.63
33%
33%

$17B
Обсяг $118.98
33%
33%

$17.2B
Обсяг $2.14K
28%
28%

$17.4B
Обсяг $544.6
29%
29%
Правила
This market will resolve to "Yes" if Johnson & Johnson's Innovative Medicine revenue for the upcoming third fiscal quarter, as reported in its official company earnings materials, is above the listed amount. Otherwise, this market will resolve to "No".
Коментарі
Коментарі